Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes
Authors
Keywords
CYP, Paclitaxel, Docetaxel, Ritonavir, Intratumoral
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 84, Issue 3, Pages 487-499
Publisher
Springer Science and Business Media LLC
Online
2019-07-15
DOI
10.1007/s00280-019-03905-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
- (2019) Adriana C. Rodriguez et al. Hormones & Cancer
- A Phase I Dose Escalation Study of Once-Weekly Oral Administration of Docetaxel as ModraDoc001 Capsule or ModraDoc006 Tablet in Combination with Ritonavir
- (2019) Vincent A. de Weger et al. CLINICAL CANCER RESEARCH
- A dose-escalation study of bi-daily once weekly oral docetaxel either as ModraDoc001 or ModraDoc006 combined with ritonavir
- (2017) Vincent A. de Weger et al. EUROPEAN JOURNAL OF CANCER
- The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma
- (2017) Mao Qixing et al. TUMOR BIOLOGY
- Resensitization of Akt Induced Docetaxel Resistance in Breast Cancer by ‘Iturin A’ a Lipopeptide Molecule from Marine Bacteria Bacillus megaterium
- (2017) Goutam Dey et al. Scientific Reports
- A phase I dose-escalation trial of bi-daily (BID) weekly oral docetaxel as ModraDoc006 in combination with ritonavir
- (2016) V.A. de Weger et al. ANNALS OF ONCOLOGY
- Cobicistat versus ritonavir boosting and differences in the drug–drug interaction profiles with co-medications
- (2016) Catia Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway
- (2016) Xiaohui Zhang et al. PLoS One
- Development of a Tumour Growth Inhibition Model to Elucidate the Effects of Ritonavir on Intratumoural Metabolism and Anti-tumour Effect of Docetaxel in a Mouse Model for Hereditary Breast Cancer
- (2015) Huixin Yu et al. AAPS Journal
- Ritonavir inhibits intratumoral docetaxel metabolism and enhances docetaxel antitumor activity in an immunocompetent mouse breast cancer model
- (2015) Jeroen J.M.A. Hendrikx et al. INTERNATIONAL JOURNAL OF CANCER
- CYP3A isoforms in Ewing's sarcoma tumours: an immunohistochemical study with clinical correlation
- (2015) Hamid Zia et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- CYP3A4 Expression in Breast Cancer and its Association with Risk Factors in Mexican Women
- (2014) Esau Floriano-Sanchez et al. Asian Pacific Journal of Cancer Prevention
- Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation
- (2014) J J M A Hendrikx et al. BRITISH JOURNAL OF CANCER
- Combination antiretroviral therapy (cART) component ritonavir significantly alters docetaxel exposure
- (2014) Michelle A. Rudek et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Assessment of clinical outcomes in breast cancer patients treated with taxanes: multi-analytical approach
- (2014) Sonam Tulsyan et al. GENE
- Systematic expression analysis of genes related to multidrug-resistance in isogenic docetaxel- and adriamycin-resistant breast cancer cell lines
- (2013) Wen-Jing Li et al. MOLECULAR BIOLOGY REPORTS
- Modulation of Xenobiotic Receptors by Steroids
- (2013) Monimoy Banerjee et al. MOLECULES
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors
- (2012) N. Mitsiades et al. CANCER RESEARCH
- Contributions of Human Enzymes in Carcinogen Metabolism
- (2012) Slobodan Rendic et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Nuclear factor-kappa B and interleukin-6 related docetaxel resistance in castration-resistant prostate cancer
- (2012) Jordi Codony-Servat et al. PROSTATE
- Ritonavir-boosted protease inhibitors in HIV therapy
- (2011) Mark W. Hull et al. ANNALS OF MEDICINE
- Ten Years of Docetaxel-Based Therapies in Prostate Adenocarcinoma: A Systematic Review and Meta-Analysis of 2244 Patients in 12 Randomized Clinical Trials
- (2011) Ary Serpa Neto et al. Clinical Genitourinary Cancer
- Resistance to docetaxel-induced apoptosis in prostate cancer cells by p38/p53/p21 signaling
- (2011) Lu Gan et al. PROSTATE
- CYP3A4 expression to predict treatment response to docetaxel for metastasis and recurrence of primary breast cancer
- (2011) Kenichi Sakurai et al. SURGERY TODAY
- Profiling the expression of cytochrome P450 in breast cancer
- (2010) Graeme I Murray et al. HISTOPATHOLOGY
- The structure and allosteric regulation of glutamate dehydrogenase
- (2010) Ming Li et al. NEUROCHEMISTRY INTERNATIONAL
- Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir
- (2010) I. F. Sevrioukova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
- (2009) S. Germano et al. CURRENT CANCER DRUG TARGETS
- Cytochrome P450-mediated metabolism in the human gut wall
- (2009) Jennifer B. Dressman et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells
- (2009) Sanjeev Kumar et al. Molecular Cancer
- Expression of Cytochrome P450 3A4 and Its Clinical Significance in Human Prostate Cancer
- (2009) Tetsuya Fujimura et al. UROLOGY
- Nuclear receptor mediated induction of cytochrome P450 3A4 by anticancer drugs: a key role for the pregnane X receptor
- (2008) S. Harmsen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Expression and activity of taxane-metobolizing enzymes in ovarian tumors
- (2007) Julie A. DeLoia et al. GYNECOLOGIC ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started